Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility 2023-07-18 19:00
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis 2023-07-18 15:00
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech' 2023-07-18 09:00
Qilian International Holding Group Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency 2023-07-17 22:30
BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program 2023-07-17 21:28
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development 2023-07-17 17:00
Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio 2023-07-14 08:29
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation 2023-07-13 18:11
Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division 2023-07-12 18:46
Bridge Biotherapeutics Joins PROLIFIC, the Prognostic Lung Fibrosis Consortium 2023-07-12 06:00
Doer Biologics Announces License Agreement with BioNTech 2023-07-11 11:49
Race executes global license agreement with City of Hope to access FTO IP 2023-07-10 19:30
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services 2023-07-07 21:00
280 Bio receives IND approval from the FDA for YL-17231 2023-07-07 20:00
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
Genesis MedTech Receives Approval for Launch in China for ArtiSential™ 2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
United Imaging, Kicking off a Birthday Celebration of Five Years in the U.S. Market, Will Debut Three New Scanners at AHRA 2023-07-06 00:00
Biosion, Inc. Appoints Furqan Ahmed, PharmD as Vice President and Head of Business Development 2023-07-05 22:05
1 70 71 72 73 74 431